Trial Details

Not Recruiting
Basic Information
Clinical ID c4974
Identifier ISRCTN79241600
Trial Title A double-blind, placebo-controlled, single and multiple ascending dose phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of CCX507-B in healthy male and female subjects
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory Bowel Diseases (IBD) such as ulcerative colitis (UC) or Crohn?s disease (CD) Digestive System
Interventions CCX507-B (30, 60 and 90 mg CCX507-B single dose and multiple doses for 7 days) or placebo. Period 1 involves subjects being randomized to CCX507-B or placebo and being dosed a single time. Period 2 involved subjects being randomized to CCX507-B or placebo
Participant Information
Sponsor ChemoCentryx, Inc. (USA)
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL